Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model

Table 2 Changes of partial biochemical indices pre- and post-treatment of HBL(mean ± SD)

Item	TBIL (mg/dL)	NH3 (µg/dL)	ALB (g/L)	CHE (U/L)	PTA%
Pre-treatment	23.08 ± 12.50	116.6 ± 23.1	29.79 ± 4.35	3801.5 ± 1710.6	17.25 ± 10.11
Post-treatment at 0 h	12.34 ± 4.39b	98.3 ± 19.5	32.57 ± 4.76	5560.9 ± 1067.6a	38.60 ± 10.25b
Post-treatment at 24 h	14.10 ± 6.08b	103.2 ± 23.5	33.13 ± 4.34	5438.5 ± 1024.3a	34.31 ± 11.75a
Post-treatment at 72 h	17.24 ± 8.34a	110.8 ± 30.6	31.42 ± 4.07	5676.2 ± 957.9a	35.20 ± 9.78b

^aP < 0.05,

^bP < 0.01, vs pre-treatment. TBIL: Total bilirubin; NH_3: Serum ammonia; ALB: Albumin; CHE: Cholinesterase; PTA: Pro-thrombin activity.